MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Deals review

TolerRx signs collaboration with Genentech

In order to access this content you must be logged in and have a subscription to PL Intelligence.

PLi

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits PL Intelligence has to offer. Find out more.

Related deals

TolerRx, Inc. Acquires Assets for Lead Product, TRX4 Expands anti-CD3 Franchise with Intellectual Property and Fully Human Antibodies

PHENOMIX SIGNS MAJOR DISCOVERY COLLABORATION WITH GENENTECH

Collaboration with Genentech on siRNA Therapeutics Development

Inpharmatica and Genentech sign collaboration

ImmunoGen and Genentech agree further collaboration

AGENSYS SIGNS COLLABORATION AND LICENSE AGREEMENT WITH GENENTECH

Incyte Genomics signs exclusive patent agreement with Genentech

Curis Announces Second Major Collaboration with Genentech

Array BioPharma and Genentech expand strategic oncology collaboration

Thermo Fisher Scientific to Collaborate with Genentech on Novel Technology Enabling Development of siRNA Therapeutics

Related categories

Therapeutic target
Immune related disorders
Immunosuppression
Industry sector
Biotechnology
Human therapeutics
Pharmaceutical
Prescription

More deals

Latest deals

Galapagos acquires Argenta Discovery’s service operations
Thermo Fisher Scientific Signs Agreement to Acquire High-Performance PCR Solution Provider, Finnzymes
Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S.
YM BioSciences completes merger with Cytopia
Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

Most viewed deals

Bayer CropScience and Janssen PMP conclude research agreement:
Recommended acquisition of Acambis plc ("Acambis") by Sanofi Pasteur Holding ("Sanofi Pasteur") by way of scheme of arrangement Posting of Scheme Document
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded to Singapore and Vietnam
Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
Bayer CropScience and Evogene to extend collaboration for rice yield improvement

By month

March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Anglonordic VII
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us